Artemis Medicare Services sees Sanjib Sen step down as Independent Director
Sanjib Sen has stepped down as an Independent Director of Artemis Medicare Services Limited on August 2, 2026, after completing his tenure. The company filed the necessary disclosures with the NSE and BSE under Regulation 30 of the SEBI Listing Regulations. This routine governance change requires the Board to appoint a successor to maintain compliance with independent director norms.
*this image is generated using AI for illustrative purposes only.
Artemis Medicare Services has announced that Sanjib Sen has ceased to be a Director of the company effective August 2, 2026. The departure follows the completion of his tenure as an Independent Director, marking a routine transition in the Board’s composition rather than a sudden exit. This change affects the independent director segment of the Board, which plays a critical role in governance and oversight for listed entities in India.
The disclosure was made on August 3, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Poonam Makkar, Company Secretary and Compliance Officer of Artemis Medicare Services, signed the notification sent to the National Stock Exchange of India Limited and BSE Limited. The filing confirms that Sen’s departure is due solely to the expiration of his term, with no adverse reasons or conflicts cited.
Details of Cessation
The regulatory filing provides specific details regarding the change in directorship. Sanjib Sen, identified by DIN 07088442, held the position of Independent Director. His tenure concluded on August 2, 2026. The company has not provided a brief profile or disclosure of relationships in this specific filing, as these fields are marked "Not Applicable" for cessations under the relevant schedule.
| Particulars | Details |
|---|---|
| Name | Sanjib Sen |
| DIN | 07088442 |
| Role Ceased | Independent Director |
| Date of Cessation | August 2, 2026 |
| Reason | Completion of tenure |
Governance Implications
The loss of an Independent Director reduces the number of independent members on the Board until a successor is appointed. Listed companies in India are required to maintain a minimum proportion of Independent Directors to ensure objective oversight of management and protect minority shareholder interests. Artemis Medicare Services must now initiate the process to identify and appoint a replacement to comply with the SEBI Listing Regulations regarding Board composition.
The company did not disclose any immediate plans for a successor appointment in this specific communication. Typically, such appointments require shareholder approval at a General Meeting or through a postal ballot, depending on the urgency and existing Board vacancies. Investors should monitor future filings for announcements regarding the nomination of a new Independent Director to restore the Board’s independent strength.
Historical Stock Returns for Artemis Medicare Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.69% | +8.99% | +13.44% | +21.92% | +25.73% | +681.46% |
How long is Artemis Medicare Services expected to take to appoint a successor, and will the interim period impact board quorum or decision-making efficiency?
What specific qualifications or industry expertise is the company prioritizing in the search for the new Independent Director to ensure effective governance oversight?
Could the vacancy in the independent director seat affect the company's compliance with SEBI's mandatory board composition ratios before the next General Meeting?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
